Concourse Financial Group Securities’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2024
Q2 | – | Hold |
|
|||||
|
2024
Q1 | – | Hold |
|
|||||
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Hold |
|
|||||
|
2023
Q2 | – | Hold |
|
|||||
|
2023
Q1 | – | Hold |
|
|||||
|
2022
Q4 | – | Hold |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2022
Q2 | – | Hold |
|
|||||
|
2022
Q1 | – | Hold |
|
|||||
|
2021
Q4 | – | Hold |
|
|||||
|
2021
Q3 | – | Hold |
|
|||||
|
2021
Q2 | – | Hold |
|